LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion of mRNA vaccines BioNTech is expanding its production capacity to dedicate up to half of its facility for mRNA vaccine production in case of public health emergencies. This presents an opportunity for partnership or sales collaboration in the field of mRNA vaccines.

Diverse oncology pipeline With a diverse portfolio of oncology product candidates, including mRNA-based therapies, CAR T cells, protein-based therapeutics, and small molecules, BioNTech offers potential collaboration opportunities for companies working in oncology research and development.

Legal challenges and patent issues BioNTech is facing legal challenges related to COVID-19 vaccine patents, with lawsuits from GSK and a notice of default from NIH over vaccine royalties. Legal services firms or IP experts could explore avenues for providing support in these matters.

Key personnel hires The recent appointment of a Chief Commercial Officer and a Chief Legal Officer presents opportunities for service providers in executive search, leadership development, and legal advisory segments looking to engage with BioNTech's top management.

Strategic partnerships BioNTech's collaborations with companies like Autolus present opportunities for strategic partnerships, joint research ventures, or supplier relationships for entities seeking to tap into BioNTech's expertise and resources.

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including QlikView, Aprimo, Dell, and more. Explore BioNTech SE's tech stack below.

  • QlikView
    Business Intelligence
  • Aprimo
    Digital Asset Management
  • Dell
    IT Infrastructure
  • Microsoft Windows Server
    Operating Systems
  • SAP Ariba
    Procurement
  • Yoast SEO
    Search Engines
  • Base SAS
    Software As A Service
  • ProvenExpert
    Widgets

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 1 format(s):
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.deJohn.Doe@biontech.de
95%
FLast@biontech.deJDoe@biontech.de
3%
First.Middle@biontech.deJohn.Michael@biontech.de
1%
First.MiddleLast@biontech.deJohn.MichaelDoe@biontech.de
1%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

Minus sign iconPlus sign iconBioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon You can contact BioNTech SE's main corporate office by phone at +49-6131-90840. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign iconBioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign iconBioNTech SE's official website is biontech.de and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon As of July 2024, BioNTech SE's annual revenue reached $18B.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign iconBioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign iconAs of July 2024, BioNTech SE has approximately 4.7K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Operating Officer: S. P.Chief Business And Commercial Officer: S. M.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign iconBioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign iconBioNTech SE's tech stack includes QlikViewAprimoDellMicrosoft Windows ServerSAP AribaYoast SEOBase SASProvenExpert.

What is BioNTech SE's email format?

Minus sign iconPlus sign iconBioNTech SE's email format typically follows the pattern of . Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon As of July 2024, BioNTech SE has raised $145M in funding. The last funding round occurred on May 29, 2024.

When was BioNTech SE founded?

Minus sign iconPlus sign iconBioNTech SE was founded in 2008.
BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany1001-5000 Employees

BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. 
  
Based on our deep expertise in mRNA vaccine development and in-house manufacturing capabilities, we are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. 

To learn more about us, please visit www.BioNTech.com. 

Our privacy statement can be found here:  https://www.biontech.com/int/en/home/data-privacy-statement.html

Section iconCompany Overview

Headquarters
An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number
+49-6131-90840
Website
biontech.de
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024.

  • $1B

    BioNTech SE's revenue is in the range of $1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.